ClinicalTrials.Veeva

Menu
B

Boeson Research | Missoula, MT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Serdexmethylphenidate
dexmethylphenidate
d-MPH
SDX
BMS-986368
Amlitelimab
Apremilast
Ruxolitinib
Troriluzole
Troriluzule

Parent organization

This site is a part of Boeson Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 23 total trials

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 1...

Active, not recruiting
Plaque Psoriasis
Drug: Apremilast

The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.

Enrolling
NonSegmental Vitiligo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine. Approx...

Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

This is an open-label, Phase 2/Phase 3, long-term extension study for treatment of participants of previous amlitelimab clinical trials in moderate t...

Invitation-only
Dermatitis Atopic
Drug: Topical calcineurin inhibitors
Drug: Topical corticosteroids

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≄ 6 to \< 18...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant (PF-07899801)

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling
Pediatric Migraine
Drug: Rimegepant/BHV3000
Drug: Matching placebo

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling
Acne
Other: Placebo
Biological: Acne mRNA vaccine

This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participan...

Enrolling
Alzheimer Disease
Agitation
Drug: Placebo
Drug: BMS-986368

Trial sponsors

Pfizer logo
Sanofi logo
Biohaven logo
C
Novavax logo
Amgen logo
BioNTech logo
Celgene logo
Gilead Sciences logo
Incyte logo

Clinical trials

Find clinical trialsTrials by location
Ā© Copyright 2026 Veeva Systems